A new study suggests that the immune checkpoint inhibitor, durvalumab, may offer new treatment options for patients living with small cell lung cancer (SCLC).

The FDA designates ARB1002 as an orphan drug, highlighting its potential as a novel treatment for pancreatic cancer amid ...

Cancer survivors can be a source of hope for others navigating life with cancer. Survivors include anyone who has been ...

Although the year brought a steady stream of new treatments, tests, and cutting-edge science, experts worry about how politics will impact innovation long term.

A few years ago, I had a patient who affectionately went by the name “Pops.” At 85 years young, he was full of life and juggling multiple health issues alongside prostate cancer, yet determined not to ...

Autonomix Medical Inc (NASDAQ:AMIX) jumped nearly 14% in premarket trading on Friday after the company released encouraging ...

New subgroup analysis shows consistent, clinically meaningful pain reduction observed from Stage 2 through Stage 4 disease, ...

Autonomix Medical is focused on developing precision nerve-targeted treatments using a transvascular RF denervation platform. The company’s approach aims to address pancreatic cancer pain, which ...

Athira Pharma, Inc. (NASDAQ: ATHA), a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for diseases with high ...

Mayo Clinic researchers developed MedEduChat, an AI-powered EHR tool that delivers personalized prostate cancer education ...

On average, we wait 867 days (approximately 2.5 years) for public coverage of certain blood cancer treatments. Fifteen other ...

A grieving widow from Caerphilly is calling for the law to change to end a postcode lottery of care for brain cancer patients.